Status: current, Defined. Date: 31-Jan 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2549891000168111 | Vyvanse (lisdexamfetamine dimesilate 20 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2549901000168110 | Vyvanse 20 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vyvanse 20 mg capsule | Is a | lisdexamfetamine dimesilate 20 mg capsule | true | Inferred relationship | Some | ||
| Vyvanse 20 mg capsule | Is a | Vyvanse | true | Inferred relationship | Some | ||
| Vyvanse 20 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Vyvanse 20 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Vyvanse 20 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 376049050 | |
| Vyvanse 20 mg capsule | has Australian BoSS | lisdexamfetamine dimesilate | true | Inferred relationship | Some | 376049049 | |
| Vyvanse 20 mg capsule | has intended active ingredient | lisdexamfetamine | true | Inferred relationship | Some | 376049049 | |
| Vyvanse 20 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vyvanse 20 mg capsule, 30, bottle | has TPUU | True | Vyvanse 20 mg capsule | Inferred relationship | Some | 1 |
| Vyvanse 20 mg capsule, 30 | has TPUU | True | Vyvanse 20 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Schedule 8 medications reference set
Trade product unit of use reference set
FHIR